Phibro Animal Health Affirms FY24 Adj. EPS $1.04-$1.16 Vs $1.10 Est.; Revenue $980M-$1.020B Vs $999.037M
Portfolio Pulse from Benzinga Newsdesk
Phibro Animal Health has affirmed its FY24 adjusted EPS guidance to be between $1.04 and $1.16, compared to the estimated $1.10. The company also expects revenue to be between $980 million and $1.020 billion, versus the estimated $999.037 million.
May 08, 2024 | 10:15 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Phibro Animal Health has reaffirmed its FY24 earnings and revenue guidance, aligning closely with analyst estimates.
The reaffirmation of Phibro Animal Health's FY24 guidance suggests stability and confidence in meeting its financial targets, which is likely to maintain investor confidence. However, since the guidance is in line with analyst expectations, the immediate impact on the stock price might be neutral, as the market may have already priced in these expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90